Global Bioresorbable Vascular Scaffold Market Size By Type (Metal BVS, Polymer BVS), By Application (Hospital & Clinic, Medical Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Bioresorbable Vascular Scaffold Market was valued at USD 450 million in 2023 and is projected to reach USD 920 million by 2031, growing at a CAGR of 9.3% during the forecast period from 2023 to 2031. The market's growth is fueled by the increasing prevalence of cardiovascular diseases, rising preference for minimally invasive procedures, and continuous technological advancements in scaffold materials. Bioresorbable vascular scaffolds (BVS) provide temporary support to blood vessels post-angioplasty and dissolve over time, reducing long-term complications associated with permanent implants.

Drivers:

Growing Cardiovascular Disease Burden:

The rising incidence of coronary artery diseases, driven by lifestyle changes, aging population, and increasing obesity rates, is a primary driver for the bioresorbable vascular scaffold market.

Technological Advancements in Scaffold Materials:

Continuous research and development are leading to improved scaffold designs, enhanced drug delivery capabilities, and better mechanical strength, fostering greater adoption of BVS.

Increasing Preference for Minimally Invasive Procedures:

Minimally invasive procedures offer faster recovery, reduced hospital stay, and minimal scarring. The growing inclination towards these procedures is boosting demand for BVS, especially in developed markets.

Restraints:

High Cost of Bioresorbable Vascular Scaffolds:

The relatively high cost of BVS compared to traditional stents remains a challenge, limiting its adoption in cost-sensitive regions.

Stringent Regulatory Framework:

The rigorous regulatory approval process for new scaffold technologies can delay product launches and impact market growth.

Opportunity:

Expansion in Emerging Markets:

Emerging economies such as China, India, and Brazil offer significant growth potential due to rising healthcare expenditure, growing awareness, and improving healthcare infrastructure.

Development of Next-generation Bioresorbable Scaffolds:

The ongoing development of innovative BVS with enhanced mechanical properties and improved resorption profiles presents lucrative opportunities for market players.

Market by System Type Insights:

Based on system type, the Polymer-based Bioresorbable Vascular Scaffold segment accounted for the largest market share in 2023. The segment’s dominance is attributed to its wide availability, proven biocompatibility, and favorable resorption characteristics. However, the Magnesium-based Bioresorbable Scaffold segment is anticipated to witness the fastest growth during the forecast period, driven by its superior mechanical strength and faster degradation profile.

Market by End-use Insights:

By end-use, the Hospitals segment held the largest market share in 2023. Hospitals remain the primary healthcare setting for cardiovascular procedures, supported by advanced infrastructure and the availability of specialized cardiologists. The Ambulatory Surgical Centers (ASCs) segment is expected to grow significantly due to the increasing adoption of minimally invasive surgeries and shorter patient recovery time.

Market by Regional Insights:

Geographically, North America dominated the Global Bioresorbable Vascular Scaffold Market in 2023, attributed to the high prevalence of cardiovascular diseases, favorable reimbursement policies, and the presence of leading market players. However, Asia-Pacific is expected to register the highest growth rate during the forecast period, driven by increasing healthcare investments, a large patient pool, and growing awareness of advanced treatment options.

Competitive Scenario:

Key players operating in the Global Bioresorbable Vascular Scaffold Market include Abbott Laboratories, Biotronik AG, Boston Scientific Corporation, REVA Medical, Elixir Medical Corporation, Arterius Ltd., and Kyoto Medical Planning Co., Ltd. These companies are focusing on technological advancements, strategic collaborations, and geographical expansion to strengthen their market positions.

Key Market Developments:

In 2023, Abbott Laboratories launched the next-generation bioresorbable scaffold with enhanced radial strength and faster resorption properties.

In 2024, Biotronik AG expanded its BVS product line with a magnesium-based scaffold designed for faster healing and superior patient outcomes.

In 2025, REVA Medical secured regulatory approval for its novel polymer-based scaffold optimized for enhanced biocompatibility and controlled drug delivery.

Scope of Work – Global Bioresorbable Vascular Scaffold Market

Report Metric Details

Market Size (2023) USD 450 million

Projected Market Size (2031) USD 920 million

CAGR (2023-2031) 9.3%

Key Segments by System Type Polymer-based Bioresorbable Scaffold, Magnesium-based Bioresorbable Scaffold

Key Segments by End-use Hospitals, Ambulatory Surgical Centers

Leading Region North America

Key Players Abbott Laboratories, Biotronik AG, Boston Scientific Corporation, REVA Medical, Elixir Medical Corporation, Arterius Ltd., Kyoto Medical Planning Co., Ltd.

FAQs

1. What is the current market size of the Global Bioresorbable Vascular Scaffold Market?

The Global Bioresorbable Vascular Scaffold Market was valued at USD 450 million in 2023.

2. What is the major growth driver of the Global Bioresorbable Vascular Scaffold Market?

The rising prevalence of cardiovascular diseases and increasing preference for minimally invasive procedures are the major growth drivers of this market.

3. Which is the largest region during the forecast period in the Global Bioresorbable Vascular Scaffold Market?

North America is the largest region in the Global Bioresorbable Vascular Scaffold Market during the forecast period.

4. Which segment accounted for the largest market share in the Global Bioresorbable Vascular Scaffold Market?

The Polymer-based Bioresorbable Vascular Scaffold segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Bioresorbable Vascular Scaffold Market?

Key market players include Abbott Laboratories, Biotronik AG, Boston Scientific Corporation, REVA Medical, Elixir Medical Corporation, Arterius Ltd., and Kyoto Medical Planning Co., Ltd.